vs
INSTEEL INDUSTRIES INC（IIIN）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是INSTEEL INDUSTRIES INC的1.4倍（$219.9M vs $159.9M），INSTEEL INDUSTRIES INC净利率更高（4.7% vs -1.0%，领先5.8%），INSTEEL INDUSTRIES INC同比增速更快（23.3% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-2.2M），过去两年INSTEEL INDUSTRIES INC的营收复合增速更高（12.0% vs 8.0%）
Insteel Industries Inc是美国领先的钢材加固产品制造商，主营焊接钢筋网、工程结构网、钢纤维等产品，主要服务北美地区非住宅建筑、基础设施、预制混凝土构件等领域客户，提供高性能建筑加固解决方案。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
IIIN vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.4倍
$159.9M
营收增速更快
IIIN
高出21.3%
2.0%
净利率更高
IIIN
高出5.8%
-1.0%
自由现金流更多
OFIX
多$19.0M
$-2.2M
两年增速更快
IIIN
近两年复合增速
8.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $159.9M | $219.9M |
| 净利润 | $7.6M | $-2.2M |
| 毛利率 | 11.3% | 71.1% |
| 营业利润率 | 6.0% | 0.2% |
| 净利率 | 4.7% | -1.0% |
| 营收同比 | 23.3% | 2.0% |
| 净利润同比 | 602.4% | 92.4% |
| 每股收益（稀释后） | $0.39 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIINOFIX
| Q4 25 | $159.9M | $219.9M | ||
| Q3 25 | $177.4M | $205.6M | ||
| Q2 25 | $179.9M | $203.1M | ||
| Q1 25 | $160.7M | $193.6M | ||
| Q4 24 | $129.7M | $215.7M | ||
| Q3 24 | $134.3M | $196.6M | ||
| Q2 24 | $145.8M | $198.6M | ||
| Q1 24 | $127.4M | $188.6M |
净利润IIINOFIX
| Q4 25 | $7.6M | $-2.2M | ||
| Q3 25 | $14.6M | $-22.8M | ||
| Q2 25 | $15.2M | $-14.1M | ||
| Q1 25 | $10.2M | $-53.1M | ||
| Q4 24 | $1.1M | $-29.1M | ||
| Q3 24 | $4.7M | $-27.4M | ||
| Q2 24 | $6.6M | $-33.4M | ||
| Q1 24 | $6.9M | $-36.0M |
毛利率IIINOFIX
| Q4 25 | 11.3% | 71.1% | ||
| Q3 25 | 16.1% | 72.2% | ||
| Q2 25 | 17.1% | 68.7% | ||
| Q1 25 | 15.3% | 62.8% | ||
| Q4 24 | 7.3% | 69.0% | ||
| Q3 24 | 9.1% | 68.7% | ||
| Q2 24 | 10.6% | 67.8% | ||
| Q1 24 | 12.3% | 67.5% |
营业利润率IIINOFIX
| Q4 25 | 6.0% | 0.2% | ||
| Q3 25 | 10.8% | -8.3% | ||
| Q2 25 | 11.0% | -7.9% | ||
| Q1 25 | 8.3% | -25.2% | ||
| Q4 24 | 1.1% | -5.3% | ||
| Q3 24 | 4.5% | -9.6% | ||
| Q2 24 | 6.0% | -12.5% | ||
| Q1 24 | 7.0% | -15.6% |
净利率IIINOFIX
| Q4 25 | 4.7% | -1.0% | ||
| Q3 25 | 8.2% | -11.1% | ||
| Q2 25 | 8.4% | -6.9% | ||
| Q1 25 | 6.4% | -27.4% | ||
| Q4 24 | 0.8% | -13.5% | ||
| Q3 24 | 3.5% | -13.9% | ||
| Q2 24 | 4.5% | -16.8% | ||
| Q1 24 | 5.4% | -19.1% |
每股收益（稀释后）IIINOFIX
| Q4 25 | $0.39 | $-0.05 | ||
| Q3 25 | $0.74 | $-0.57 | ||
| Q2 25 | $0.78 | $-0.36 | ||
| Q1 25 | $0.52 | $-1.35 | ||
| Q4 24 | $0.06 | $-0.76 | ||
| Q3 24 | $0.24 | $-0.71 | ||
| Q2 24 | $0.34 | $-0.88 | ||
| Q1 24 | $0.35 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.6M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $358.8M | $450.0M |
| 总资产 | $456.1M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IIINOFIX
| Q4 25 | $15.6M | $82.0M | ||
| Q3 25 | $38.6M | $62.9M | ||
| Q2 25 | $53.7M | $65.6M | ||
| Q1 25 | $28.4M | $58.0M | ||
| Q4 24 | $36.0M | $83.2M | ||
| Q3 24 | $111.5M | $30.1M | ||
| Q2 24 | $97.7M | $26.4M | ||
| Q1 24 | $83.9M | $27.0M |
总债务IIINOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益IIINOFIX
| Q4 25 | $358.8M | $450.0M | ||
| Q3 25 | $371.5M | $442.5M | ||
| Q2 25 | $356.2M | $458.3M | ||
| Q1 25 | $341.4M | $458.3M | ||
| Q4 24 | $331.6M | $503.1M | ||
| Q3 24 | $350.9M | $525.9M | ||
| Q2 24 | $346.0M | $546.0M | ||
| Q1 24 | $340.6M | $570.3M |
总资产IIINOFIX
| Q4 25 | $456.1M | $850.6M | ||
| Q3 25 | $462.6M | $832.6M | ||
| Q2 25 | $471.9M | $837.2M | ||
| Q1 25 | $421.9M | $823.1M | ||
| Q4 24 | $404.7M | $893.3M | ||
| Q3 24 | $422.6M | $867.9M | ||
| Q2 24 | $414.6M | $882.0M | ||
| Q1 24 | $397.2M | $906.0M |
负债/权益比IIINOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-701.0K | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-2.2M | $16.8M |
| 自由现金流率自由现金流/营收 | -1.4% | 7.6% |
| 资本支出强度资本支出/营收 | 0.9% | 4.9% |
| 现金转化率经营现金流/净利润 | -0.09× | — |
| 过去12个月自由现金流最近4个季度 | $439.0K | $-1.3M |
8季度趋势，按日历期对齐
经营现金流IIINOFIX
| Q4 25 | $-701.0K | $27.7M | ||
| Q3 25 | $-17.0M | $12.4M | ||
| Q2 25 | $28.5M | $11.6M | ||
| Q1 25 | $-3.3M | $-18.4M | ||
| Q4 24 | $19.0M | $23.7M | ||
| Q3 24 | $16.2M | $11.7M | ||
| Q2 24 | $18.8M | $9.0M | ||
| Q1 24 | $1.4M | $-18.6M |
自由现金流IIINOFIX
| Q4 25 | $-2.2M | $16.8M | ||
| Q3 25 | $-18.7M | $2.5M | ||
| Q2 25 | $26.9M | $4.5M | ||
| Q1 25 | $-5.5M | $-25.1M | ||
| Q4 24 | $16.3M | $15.2M | ||
| Q3 24 | $14.5M | $6.3M | ||
| Q2 24 | $15.5M | $-360.0K | ||
| Q1 24 | $-580.0K | $-29.1M |
自由现金流率IIINOFIX
| Q4 25 | -1.4% | 7.6% | ||
| Q3 25 | -10.6% | 1.2% | ||
| Q2 25 | 15.0% | 2.2% | ||
| Q1 25 | -3.5% | -13.0% | ||
| Q4 24 | 12.6% | 7.0% | ||
| Q3 24 | 10.8% | 3.2% | ||
| Q2 24 | 10.7% | -0.2% | ||
| Q1 24 | -0.5% | -15.4% |
资本支出强度IIINOFIX
| Q4 25 | 0.9% | 4.9% | ||
| Q3 25 | 1.0% | 4.8% | ||
| Q2 25 | 0.9% | 3.5% | ||
| Q1 25 | 1.4% | 3.5% | ||
| Q4 24 | 2.1% | 4.0% | ||
| Q3 24 | 1.3% | 2.7% | ||
| Q2 24 | 2.2% | 4.7% | ||
| Q1 24 | 1.5% | 5.6% |
现金转化率IIINOFIX
| Q4 25 | -0.09× | — | ||
| Q3 25 | -1.17× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | -0.32× | — | ||
| Q4 24 | 17.56× | — | ||
| Q3 24 | 3.48× | — | ||
| Q2 24 | 2.86× | — | ||
| Q1 24 | 0.20× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
